NO140058C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater

Info

Publication number
NO140058C
NO140058C NO327/73A NO32773A NO140058C NO 140058 C NO140058 C NO 140058C NO 327/73 A NO327/73 A NO 327/73A NO 32773 A NO32773 A NO 32773A NO 140058 C NO140058 C NO 140058C
Authority
NO
Norway
Prior art keywords
piperidinoalcanol
preparation
therapeutically active
active substituted
analogical procedure
Prior art date
Application number
NO327/73A
Other languages
English (en)
Norwegian (no)
Other versions
NO140058B (no
Inventor
Albert Anthony Carr
Clyde Richard Kinsolving
Donald Ralph Meyer
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of NO140058B publication Critical patent/NO140058B/no
Publication of NO140058C publication Critical patent/NO140058C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO327/73A 1972-01-28 1973-01-26 Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater NO140058C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00221822A US3829433A (en) 1972-01-28 1972-01-28 Substituted piperidinoalkanone oxime derivatives

Publications (2)

Publication Number Publication Date
NO140058B NO140058B (no) 1979-03-19
NO140058C true NO140058C (no) 1979-07-04

Family

ID=22829544

Family Applications (1)

Application Number Title Priority Date Filing Date
NO327/73A NO140058C (no) 1972-01-28 1973-01-26 Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater

Country Status (27)

Country Link
US (1) US3829433A (US06174465-20010116-C00003.png)
JP (1) JPS5112631B2 (US06174465-20010116-C00003.png)
AR (1) AR195315A1 (US06174465-20010116-C00003.png)
AT (1) AT321915B (US06174465-20010116-C00003.png)
AU (1) AU463692B2 (US06174465-20010116-C00003.png)
BE (1) BE794596A (US06174465-20010116-C00003.png)
CA (1) CA978947A (US06174465-20010116-C00003.png)
CH (1) CH582672A5 (US06174465-20010116-C00003.png)
CS (1) CS177835B2 (US06174465-20010116-C00003.png)
DD (1) DD103240A5 (US06174465-20010116-C00003.png)
DE (2) DE2365906A1 (US06174465-20010116-C00003.png)
DK (1) DK136312B (US06174465-20010116-C00003.png)
ES (1) ES410729A1 (US06174465-20010116-C00003.png)
FR (1) FR2181691B1 (US06174465-20010116-C00003.png)
GB (1) GB1413139A (US06174465-20010116-C00003.png)
HU (1) HU166478B (US06174465-20010116-C00003.png)
IE (1) IE37201B1 (US06174465-20010116-C00003.png)
IL (1) IL41059A (US06174465-20010116-C00003.png)
LU (1) LU66911A1 (US06174465-20010116-C00003.png)
NL (1) NL7300870A (US06174465-20010116-C00003.png)
NO (1) NO140058C (US06174465-20010116-C00003.png)
PH (1) PH9201A (US06174465-20010116-C00003.png)
PL (1) PL89096B1 (US06174465-20010116-C00003.png)
SE (1) SE382060B (US06174465-20010116-C00003.png)
SU (1) SU461497A3 (US06174465-20010116-C00003.png)
YU (1) YU35582B (US06174465-20010116-C00003.png)
ZA (1) ZA728543B (US06174465-20010116-C00003.png)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941795A (en) * 1974-02-08 1976-03-02 Richardson-Merrell Inc. α-ARYL-4-SUBSTITUTED PIPERIDINOALKANOL DERIVATIVES
US3931197A (en) * 1974-02-08 1976-01-06 Richardson-Merrell Inc. Substituted piperidine derivatives
US3946022A (en) * 1974-03-04 1976-03-23 Richardson-Merrell Inc. Piperidine derivatives
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4285958A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof
US4285957A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
US4254130A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4370335A (en) * 1982-02-02 1983-01-25 Mcneilab, Inc. Antisecretory 4-diphenylmethyl-1-[(oxoalkyl)imino]methyl-piperidines and their derivatives
EP0294183B1 (en) * 1987-06-02 1994-03-30 Ajinomoto Co., Inc. Use of ethylamine derivatives as antihypertensive agents
FR2643373B1 (fr) * 1989-01-10 1993-12-31 Adir Cie Nouveaux derives des bisarylalcenes, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
DE3917241A1 (de) * 1989-05-26 1990-11-29 Schaper & Bruemmer Gmbh 4-(hydroxydiphenylmethyl)-1-piperidyl-phenylalkan-derivate
PT1026147E (pt) * 1993-06-24 2004-04-30 Albany Molecular Res Inc Compostos uteis como intermediarios na producao de derivados de piperidina
US20020007068A1 (en) * 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
CN1275916C (zh) 1993-06-25 2006-09-20 阿温蒂斯公司 用于制备抗组胺哌啶衍生物的新中间体
US6147216A (en) * 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
AU1424595A (en) * 1994-01-12 1995-08-01 Taisho Pharmaceutical Co., Ltd. Thiophene oxime derivative
US6201124B1 (en) * 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6153754A (en) 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6613907B2 (en) 2000-11-08 2003-09-02 Amr Technology, Inc. Process for the production of piperidine derivatives with microorganisms

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3081303A (en) * 1961-10-13 1963-03-12 Searle & Co 1-aminoalkyl-alpha, alpha-diphenylpiperidine-methanols

Also Published As

Publication number Publication date
US3829433A (en) 1974-08-13
JPS5112631B2 (US06174465-20010116-C00003.png) 1976-04-21
FR2181691A1 (US06174465-20010116-C00003.png) 1973-12-07
YU35582B (en) 1981-04-30
DE2303246C3 (de) 1981-04-09
YU3373A (en) 1980-09-25
IL41059A0 (en) 1973-02-28
IE37201B1 (en) 1977-05-25
SE382060B (sv) 1976-01-12
IL41059A (en) 1975-08-31
AR195315A1 (es) 1973-09-28
FR2181691B1 (US06174465-20010116-C00003.png) 1975-10-10
PH9201A (en) 1975-07-03
DE2365906A1 (de) 1976-10-21
DE2303246A1 (de) 1973-08-02
SU461497A3 (ru) 1975-02-25
ES410729A1 (es) 1976-04-01
LU66911A1 (US06174465-20010116-C00003.png) 1973-07-27
HU166478B (US06174465-20010116-C00003.png) 1975-03-28
NO140058B (no) 1979-03-19
DD103240A5 (US06174465-20010116-C00003.png) 1974-01-12
CS177835B2 (US06174465-20010116-C00003.png) 1977-08-31
IE37201L (en) 1973-07-28
GB1413139A (en) 1975-11-05
AU4989772A (en) 1974-06-13
AU463692B2 (en) 1975-07-31
BE794596A (fr) 1973-05-16
ZA728543B (en) 1973-08-29
JPS4885577A (US06174465-20010116-C00003.png) 1973-11-13
PL89096B1 (US06174465-20010116-C00003.png) 1976-10-30
NL7300870A (US06174465-20010116-C00003.png) 1973-07-31
DK136312C (US06174465-20010116-C00003.png) 1978-02-27
AT321915B (de) 1975-04-25
CH582672A5 (US06174465-20010116-C00003.png) 1976-12-15
DE2303246B2 (de) 1980-06-19
DK136312B (da) 1977-09-26
CA978947A (en) 1975-12-02

Similar Documents

Publication Publication Date Title
NO140059B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinderivater
NO793013L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater
NO139560C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
NO137941C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt tri-p-toluensulfonat av s-adenosyl-l-methionin
NO140381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner
NO138565C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO137694C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner
NO136094C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive d-1-(4-amino-fenyl)-2-alkylamino-etanol-derivater.
NO140057C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive alfa-aryl-4-substituerte piperidinoalkanol-derivater
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO138336C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzofuranderivater
NO140597C (no) Analogifremgangsmaate ved fremstillingen av terapeutisk aktive 8-azapurin-6-on-derivater
NO140670C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater
NO140821C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrido-pyrimidin-derivater
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO138063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive normorfinon-derivater
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO143499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO140299C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-oner
NO139050C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater
NO138251C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzylaminer
NO138285C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive lincomycinderivater
NO137695C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-tienylmetyl-heterocykliske forbindelser
NO137727C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-hydroksy-3-metyltriazener